E-cadherin gene mutations provide clues to diffuse type gastric carcinomas - PubMed (original) (raw)
. 1994 Jul 15;54(14):3845-52.
Affiliations
- PMID: 8033105
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
K F Becker et al. Cancer Res. 1994.
Abstract
The calcium-dependent homophilic cell adhesion molecule and candidate suppressor gene, E (epithelial)-cadherin, plays a major role in the organization and integrity of most epithelial tissues. Diffusely growing gastric carcinomas show markedly reduced homophilic cell-to-cell interactions. We speculated that mutations in the E-cadherin gene may be responsible for the scattered phenotype of this type of carcinoma. For that reason we have examined E-cadherin in 26 diffuse type, 20 intestinal type and 7 mixed gastric carcinomas (Laurén's classification) at the DNA, RNA, and protein levels. Reverse transcription polymerase chain reaction and direct sequencing of amplified E-cadherin complementary DNA fragments revealed inframe skipping of either exon 8 or exon 9 in 10 patients with diffuse tumors and an exon 9 deletion in one patient with a mixed carcinoma; both exons encode putative calcium binding domains. These alterations were not seen in nontumorous gastric tissues. Splice site mutations responsible for the exon deletions were identified in six of these patients, eliminating the possibility of alternative splicing mechanisms. Five of these splice site alterations were confirmed as somatic mutations. Non-splice site mutations were observed in three diffuse type tumors, namely a 69-base pair deletion of exon 10 and two point mutations, one of which destroys a putative calcium binding region. Immunohistochemical evaluation showed E-cadherin immunoreactivity in tumors and lymph node metastases of patients expressing abnormal mRNA. The allelic status of the E-cadherin gene was analyzed in one patient, revealing loss of heterozygosity with retention of a mutated E-cadherin allele. Overall, E-cadherin mutations were identified in 50% (13 of 26) of the diffuse type and in 14% (1 of 7) of the mixed carcinomas. In contrast, two silent E-cadherin mutations (not changing the amino acid sequence) were detected in two tumors of the intestinal type. Our study provides strong in vivo evidence that E-cadherin gene mutations may contribute to the development of diffusely growing gastric carcinomas and support a tumor/metastasis suppressor gene hypothesis.
Similar articles
- E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simões M. Machado JC, et al. Lab Invest. 1999 Apr;79(4):459-65. Lab Invest. 1999. PMID: 10211998 - Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Tamura G, et al. Jpn J Cancer Res. 1996 Nov;87(11):1153-9. doi: 10.1111/j.1349-7006.1996.tb03125.x. Jpn J Cancer Res. 1996. PMID: 9045944 Free PMC article. - E-cadherin gene mutations in human gastric carcinoma cell lines.
Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S. Oda T, et al. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1858-62. doi: 10.1073/pnas.91.5.1858. Proc Natl Acad Sci U S A. 1994. PMID: 8127895 Free PMC article. - Mutations of the human E-cadherin (CDH1) gene.
Berx G, Becker KF, Höfler H, van Roy F. Berx G, et al. Hum Mutat. 1998;12(4):226-37. doi: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 1998. PMID: 9744472 Review. - E-cadherin as a tumor (invasion) suppressor gene.
Birchmeier W. Birchmeier W. Bioessays. 1995 Feb;17(2):97-9. doi: 10.1002/bies.950170203. Bioessays. 1995. PMID: 7748170 Review.
Cited by
- Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics.
Wu LW, Jang SJ, Shapiro C, Fazlollahi L, Wang TC, Ryeom SW, Moy RH. Wu LW, et al. Target Oncol. 2024 Sep 13. doi: 10.1007/s11523-024-01097-2. Online ahead of print. Target Oncol. 2024. PMID: 39271577 Review. - ATM, BLM, and CDH1 gene co-mutations in a high-grade endometrial stromal sarcoma patient with multiple abdominal cavity metastases: a case report and literature review.
Li N, Yan Y, Li Y, Yang Y, Dai C, Li N. Li N, et al. BMC Geriatr. 2024 Jul 15;24(1):603. doi: 10.1186/s12877-024-05201-z. BMC Geriatr. 2024. PMID: 39009979 Free PMC article. Review. - Lobular Breast Carcinoma Mimicking a Primary Gastric Malignancy.
Anguiano-Albarran R, Obi F, Pradeep S, Cain D, Bartlett B, Simien M. Anguiano-Albarran R, et al. Cureus. 2023 Jun 13;15(6):e40371. doi: 10.7759/cureus.40371. eCollection 2023 Jun. Cureus. 2023. PMID: 37456366 Free PMC article. - A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1.
Yan Q, Wu Y, Li D, Li Y. Yan Q, et al. J Oncol. 2022 Oct 22;2022:2830634. doi: 10.1155/2022/2830634. eCollection 2022. J Oncol. 2022. PMID: 36317124 Free PMC article. - Evaluation of immunohistochemical expression of E-cadherin in pleomorphic adenoma and adenoid cystic carcinoma.
Sangala BN, Raghunath V, Kavle P, Gupta A, Gotmare SS, Andey VS. Sangala BN, et al. J Oral Maxillofac Pathol. 2022 Jan-Mar;26(1):65-71. doi: 10.4103/jomfp.jomfp_337_21. Epub 2022 Mar 31. J Oral Maxillofac Pathol. 2022. PMID: 35571293 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases